FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs

(MedPage Today) -- The FDA is "leaning in" to cell and gene therapies, expressing a willingness to use the accelerated approval pathway for these products, particularly as new leadership is set to take charge of a recently revamped office. That...
Source: MedPage Today Public Health - Category: American Health Source Type: news